Investigation of Fasciculation and Elongation Protein ζ-1 (FEZ1) in Peripheral Blood Reveals Differences in Gene Expression in Patients with Schizophrenia

1. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007; 64(1): 19-28.10.1001/archpsyc.64.1.19Search in Google Scholar

2. Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi Le, Arinami T, et al. Meta analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry. 2009; 14(8): 774-785.10.1038/mp.2008.135Search in Google Scholar

3. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009; 460(7256): 753-757.10.1038/nature08192Search in Google Scholar

4. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009; 460(7256): 744-747.10.1038/nature08186Search in Google Scholar

5. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460(7256): 748-752.10.1038/nature08185Search in Google Scholar

6. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W, et al. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res. 2004; 67(1): 41-52.10.1016/S0920-9964(03)00151-8Search in Google Scholar

7. Kuzman MR, Medved V, Terzic J, Krainc D. Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophrenia. J Psychiatr Res. 2009; 43(13): 1073-1037.10.1016/j.jpsychires.2009.03.00519358997Search in Google Scholar

8. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, Fujita T, et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry. 2003; 8(7): 685-694.10.1038/sj.mp.400135212874605Search in Google Scholar

9. Lipska BK, Peters T, Hyde TM, Halim N, Horowitz C, Mitkus T, et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet. 2006; 15(8): 1245-1258.10.1093/hmg/ddl04016510495Search in Google Scholar

10. Sakae N, Yamasaki N, Kitaichi K, Fukuda T, Yamada M, Yoshikawa H, et al. Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. Hum Mol Genet. 2008; 17(20): 3191-3203.10.1093/hmg/ddn21518647754Search in Google Scholar

11. Moens LN, de Rijk P, Reumers J, van den Bossche MJ, Glassee W, de Zutter S, et al. Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a Northern Swedish population. PLoS ONE. 2011; 6(8): e23450. doi: 10.1371/ journal.pone.0023450.10.1371/journal.pone.0023450315493921853134Search in Google Scholar

12. Chubb JE, Bradshaw NJ, Soares DC, Poeteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry. 2008; 13(1): 36-64.10.1038/sj.mp.400210617912248Search in Google Scholar

13. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006; 15(21): 3132-3145.10.1093/hmg/ddl253279994316984965Search in Google Scholar

14. Wang J, Robinson JF, Khan HM, Carter DE, McKinney J, Miskie BA, et al. Optimizing RNA extraction yield from whole blood for microarray gene expression analysis. Clin Biochem. 2004; 37(9): 741-744.10.1016/j.clinbiochem.2004.03.01315329310Search in Google Scholar

15. Yu Z, Ono C, Kim HB, Komatsu H, Tanabe Y, Sakae N, et al. Four mood stabilizers commonly induce FEZ1 expression in human astrocytes. Bipolar Disord. 2011; 13(5-6): 486-499.10.1111/j.1399-5618.2011.00946.x22017218Search in Google Scholar

16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) method. Methods. 2001; 25(4): 402-408.10.1006/meth.2001.126211846609Search in Google Scholar

17. Austin CP, Ky B, Ma L, Morris JA, Shughrue PJ. Expression of disrupted-in-Schizophrenia-1, a schizophre-nia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience. 2004; 124(1): 3-10.10.1016/j.neuroscience.2003.11.01014960334Search in Google Scholar

18. Honda A, Miyoshi K, Baba K, Taniguchi M, Koyama Y, Kuroda S, et al. Expression of fasciculation and elongation protein zeta-1 (FEZ1) in the developing rat brain. Brain Res Mol Brain Res. 2004; 122(1): 89-92.10.1016/j.molbrainres.2003.11.02014992819Search in Google Scholar

19. Koga M, Ishiguro H, Horiuchi Y, Albalushi T, Inada T, Iwata N, et al. Failure to confirm the association between the FEZ1 gene and schizophrenia in a Japanese population. Neurosci. Lett. 2007; 417(3): 326-329.Search in Google Scholar

20. Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari MR, Ahmadkhaniha H, Thiagalingam S, et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res. 2011; 45(11): 1432-1438. 10.1016/j.jpsychires.2011.06.01321820670Search in Google Scholar